The Impact of Beta Blockers on Survival in Heart Transplant Recipients: Insights from the Zabrze HTx Registry.
Conclusions: The use of BBs in our cohort of patients after HTx was not associated with survival benefits.
PMID: 32774914 [PubMed]
Source: Cardiology Research and Practice - Category: Cardiology Authors: Kubiak GM, Kwieciński R, Ciarka A, Tukiendorf A, Przybyłowski P, Hrapkowicz T, Zembala MO Tags: Cardiol Res Pract Source Type: research
More News: Atenolol | Beta-Blockers | Bisoprolol | Cardiology | Coreg | Heart | Heart Transplant | Toprol | Transplant Surgery | Transplants